Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk

Detalhes bibliográficos
Autor(a) principal: Barber, Katrin D. Mayer
Data de Publicação: 2014
Outros Autores: Andrade, Bruno de Bezerril, Oland, Sandra D, Amaral, Eduardo Pinheiro, Barber, Daniel L, Gonzales, Jacqueline, Derrick, Steven C, Shi, Ruiru, Kumar, Nathella Pavan, Wei, Wang, Yuan, Xing, Zhang, Guolong, Cai, Ying, Babu, Subash, Catalfamo, Marta, Salazar, Andres M, Via, Laura E, Barry, Clifton E, Sher, Alan
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/25831
Resumo: Andrade, Bruno Bezerril. “Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta à informação no documento”. 1Immunobiology Section, Laboratory of Parasitic Diseases (LPD), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland 20892, USA. 2Department of Immunology, Biomedical Sciences Institutes, University of Sao Paulo, 05508-900 Sao Paulo, Brazil. 3T Lymphocyte Biology Unit, LPD, NIAID, NIH, Bethesda, Maryland 20892, USA. 4Tuberculosis Research Section, Laboratory of Clinical Infectious Disease, NIAID, NIH, Bethesda, Maryland 20892, USA. 5Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA. 6Henan Chest Hospital, 450003 Zhengzhou, China. 7NIH, International Center for Excellence in Research, 600 031 Chennai, India. 8National Institute for Research in Tuberculosis (NIRT), 600 031 Chennai, India. 9Sino-US International Research Center for Tuberculosis, and Henan Public Health Center, 450003 Zhengzhou, China. 10Helminth Immunology Section, LPD, NIAID, NIH, Bethesda, Maryland 20892, USA. 11Clinical and Molecular Retrovirology Section, Laboratory of Immunoregulation, NIAID, NIH, Bethesda, Maryland 20892, USA. 12Oncovir Inc., Washington, Washington DC 20008, USA.
id CRUZ_e10ff996cc394ecb881ebb4c7b6b3d9a
oai_identifier_str oai:www.arca.fiocruz.br:icict/25831
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Barber, Katrin D. MayerAndrade, Bruno de BezerrilOland, Sandra DAmaral, Eduardo PinheiroBarber, Daniel LGonzales, JacquelineDerrick, Steven CShi, RuiruKumar, Nathella PavanWei, WangYuan, XingZhang, GuolongCai, YingBabu, SubashCatalfamo, MartaSalazar, Andres MVia, Laura EBarry, Clifton ESher, Alan2018-04-12T18:19:08Z2018-04-12T18:19:08Z2014BARBER, K. D. M. et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature, 20140028-0836https://www.arca.fiocruz.br/handle/icict/2583110.1038/nature13489Andrade, Bruno Bezerril. “Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta à informação no documento”. 1Immunobiology Section, Laboratory of Parasitic Diseases (LPD), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland 20892, USA. 2Department of Immunology, Biomedical Sciences Institutes, University of Sao Paulo, 05508-900 Sao Paulo, Brazil. 3T Lymphocyte Biology Unit, LPD, NIAID, NIH, Bethesda, Maryland 20892, USA. 4Tuberculosis Research Section, Laboratory of Clinical Infectious Disease, NIAID, NIH, Bethesda, Maryland 20892, USA. 5Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA. 6Henan Chest Hospital, 450003 Zhengzhou, China. 7NIH, International Center for Excellence in Research, 600 031 Chennai, India. 8National Institute for Research in Tuberculosis (NIRT), 600 031 Chennai, India. 9Sino-US International Research Center for Tuberculosis, and Henan Public Health Center, 450003 Zhengzhou, China. 10Helminth Immunology Section, LPD, NIAID, NIH, Bethesda, Maryland 20892, USA. 11Clinical and Molecular Retrovirology Section, Laboratory of Immunoregulation, NIAID, NIH, Bethesda, Maryland 20892, USA. 12Oncovir Inc., Washington, Washington DC 20008, USA.NIAID Intramural Research program and a Concept Acceleration Program-AwardMúltipla – ver em NotasTuberculosis remains second only to HIV/AIDS as the leading cause of mortality worldwide due to a single infectious agent. Despite chemotherapy, the global tuberculosis epidemic has intensified because of HIV co-infection, the lack of an effective vaccine and the emergence of multi-drug-resistant bacteria. Alternative host-directed strategies could be exploited to improve treatment efficacy and outcome, contain drug-resistant strains and reduce disease severity and mortality. The innate inflammatory response elicited by Mycobacterium tuberculosis (Mtb) represents a logical host target. Here we demonstrate that interleukin-1 (IL-1) confers host resistance through the induction of eicosanoids that limit excessive type I interferon (IFN) production and foster bacterial containment. We further show that, in infected mice and patients, reduced IL-1 responses and/or excessive type I IFN induction are linked to an eicosanoid imbalance associated with disease exacerbation. Host-directed immunotherapy with clinically approved drugs that augment prostaglandin E2 levels in these settings prevented acute mortality of Mtb-infected mice. Thus, IL-1 and type I IFNs represent two major counter-regulatory classes of inflammatory cytokines that control the outcome of Mtb infection and are functionally linked via eicosanoids. Our findings establish proof of concept for host-directed treatment strategies that manipulate the host eicosanoid network and represent feasible alternatives to conventional chemotherapy.engNature Publishing GroupTuberculose PulmonarMycobacterium tuberculosisInterleucina-1VacinaInfecçãoTuberculosis PulmonaryMycobacterium tuberculosisInterleukin-1VaccineInfectionHost-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalkinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/25831/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALBarber KDM Host-directed....pdfBarber KDM Host-directed....pdfapplication/pdf1524781https://www.arca.fiocruz.br/bitstream/icict/25831/2/Barber%20KDM%20Host-directed....pdfeb635d7b2a92a1081db2fea05b1a95daMD52TEXTBarber KDM Host-directed....pdf.txtBarber KDM Host-directed....pdf.txtExtracted texttext/plain82281https://www.arca.fiocruz.br/bitstream/icict/25831/3/Barber%20KDM%20Host-directed....pdf.txt19d7bad923c15f3a5dad7ab6af09e83bMD53icict/258312023-03-15 14:34:07.568oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:34:07Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
title Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
spellingShingle Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Barber, Katrin D. Mayer
Tuberculose Pulmonar
Mycobacterium tuberculosis
Interleucina-1
Vacina
Infecção
Tuberculosis Pulmonary
Mycobacterium tuberculosis
Interleukin-1
Vaccine
Infection
title_short Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
title_full Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
title_fullStr Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
title_full_unstemmed Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
title_sort Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
author Barber, Katrin D. Mayer
author_facet Barber, Katrin D. Mayer
Andrade, Bruno de Bezerril
Oland, Sandra D
Amaral, Eduardo Pinheiro
Barber, Daniel L
Gonzales, Jacqueline
Derrick, Steven C
Shi, Ruiru
Kumar, Nathella Pavan
Wei, Wang
Yuan, Xing
Zhang, Guolong
Cai, Ying
Babu, Subash
Catalfamo, Marta
Salazar, Andres M
Via, Laura E
Barry, Clifton E
Sher, Alan
author_role author
author2 Andrade, Bruno de Bezerril
Oland, Sandra D
Amaral, Eduardo Pinheiro
Barber, Daniel L
Gonzales, Jacqueline
Derrick, Steven C
Shi, Ruiru
Kumar, Nathella Pavan
Wei, Wang
Yuan, Xing
Zhang, Guolong
Cai, Ying
Babu, Subash
Catalfamo, Marta
Salazar, Andres M
Via, Laura E
Barry, Clifton E
Sher, Alan
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Barber, Katrin D. Mayer
Andrade, Bruno de Bezerril
Oland, Sandra D
Amaral, Eduardo Pinheiro
Barber, Daniel L
Gonzales, Jacqueline
Derrick, Steven C
Shi, Ruiru
Kumar, Nathella Pavan
Wei, Wang
Yuan, Xing
Zhang, Guolong
Cai, Ying
Babu, Subash
Catalfamo, Marta
Salazar, Andres M
Via, Laura E
Barry, Clifton E
Sher, Alan
dc.subject.other.pt_BR.fl_str_mv Tuberculose Pulmonar
Mycobacterium tuberculosis
Interleucina-1
Vacina
Infecção
topic Tuberculose Pulmonar
Mycobacterium tuberculosis
Interleucina-1
Vacina
Infecção
Tuberculosis Pulmonary
Mycobacterium tuberculosis
Interleukin-1
Vaccine
Infection
dc.subject.en.pt_BR.fl_str_mv Tuberculosis Pulmonary
Mycobacterium tuberculosis
Interleukin-1
Vaccine
Infection
description Andrade, Bruno Bezerril. “Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta à informação no documento”. 1Immunobiology Section, Laboratory of Parasitic Diseases (LPD), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland 20892, USA. 2Department of Immunology, Biomedical Sciences Institutes, University of Sao Paulo, 05508-900 Sao Paulo, Brazil. 3T Lymphocyte Biology Unit, LPD, NIAID, NIH, Bethesda, Maryland 20892, USA. 4Tuberculosis Research Section, Laboratory of Clinical Infectious Disease, NIAID, NIH, Bethesda, Maryland 20892, USA. 5Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA. 6Henan Chest Hospital, 450003 Zhengzhou, China. 7NIH, International Center for Excellence in Research, 600 031 Chennai, India. 8National Institute for Research in Tuberculosis (NIRT), 600 031 Chennai, India. 9Sino-US International Research Center for Tuberculosis, and Henan Public Health Center, 450003 Zhengzhou, China. 10Helminth Immunology Section, LPD, NIAID, NIH, Bethesda, Maryland 20892, USA. 11Clinical and Molecular Retrovirology Section, Laboratory of Immunoregulation, NIAID, NIH, Bethesda, Maryland 20892, USA. 12Oncovir Inc., Washington, Washington DC 20008, USA.
publishDate 2014
dc.date.issued.fl_str_mv 2014
dc.date.accessioned.fl_str_mv 2018-04-12T18:19:08Z
dc.date.available.fl_str_mv 2018-04-12T18:19:08Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv BARBER, K. D. M. et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature, 2014
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/25831
dc.identifier.issn.pt_BR.fl_str_mv 0028-0836
dc.identifier.doi.none.fl_str_mv 10.1038/nature13489
identifier_str_mv BARBER, K. D. M. et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature, 2014
0028-0836
10.1038/nature13489
url https://www.arca.fiocruz.br/handle/icict/25831
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Nature Publishing Group
publisher.none.fl_str_mv Nature Publishing Group
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/25831/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/25831/2/Barber%20KDM%20Host-directed....pdf
https://www.arca.fiocruz.br/bitstream/icict/25831/3/Barber%20KDM%20Host-directed....pdf.txt
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
eb635d7b2a92a1081db2fea05b1a95da
19d7bad923c15f3a5dad7ab6af09e83b
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1813008844657262592